Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077Elizabeth E. Tolley, Raphael J. Landovitz, David M. Margolis et al.|AIDS and Behavior|2020Cited by 92